FDA Approves More ‘Rapid’ COVID-19 Coronavirus Tests For Use On Frontlines The U. S. Food and Drug Administration is approving more rapid molecular diagnostic tests that can be used in temporary screening locations, doctor’s office labs and nursing homes to detect the Coronavirus strain COVID-19 in less than a half hour.